Notícias e Atividades da Calidi Biotherapeutics

Calidi Biotherapeutics é uma empresa listada sob o símbolo CLDI (US).

Veja o organograma con seus 12 executivos principais

Biografias mais buscadas da Calidi Biotherapeutics

• Eric Poma, Chief Executive Officer
• Scott Leftwich, Director
• Allan Camaisa, Director

Recentes movimentos de executivos em Calidi Biotherapeutics

• Corsee Sanders, ingressou na Companhia como Director  (Notícia publicada em 23 de junho de 2026).

Criar um alerta
para seguir os movimentos de executivos da Calidi Biotherapeutics.

Calidi Biotherapeutics possui 2.430 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Tempus has announced the acquisition of Personalis  (publicado em 20 de julho de 2026).
• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Robert Gould - Board Member da Fulcrum Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Calidi Biotherapeutics

• Calidi Biotherapeutics - News
• Calidi Biotherapeutics Presents Systemic Oncolytic Platform with CD55-Enhanced Expression and IL-15 Superagonist Payload at ASCO Annual Meeting - Calidi Biotherapeutics, Inc
• News Coverage - Calidi Biotherapeutics, Inc
• Press Release - Calidi Biotherapeutics, Inc
• Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights | Newsroom - Calidi Biotherapeutics
• Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 | Newsroom - Calidi Biotherapeutics
• Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy  Platform at AACR Annual Meeting | Newsroom - Calidi Biotherapeutics
• Calidi Newsroom | Latest Updates & Breakthroughs
• Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor | Newsroom - Calidi Biotherapeutics
• Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement | Newsroom - Calidi Biotherapeutics
• View more press releases Close

Redes sociais sobre Calidi Biotherapeutics

• Calidi Biotherapeutics na Wikipedia, Google News e Yahoo Finance
• Calidi Biotherapeutics na LinkedIn, X (Twitter) e YouTube